I strongly oppose any proposal that would allow the VA to bill a veteran's private insurance for treatment of a service-connected disability.
Ann Kirkpatrick
The Public Record
Ann Kirkpatrick is a Democratic politician from Arizona who has served in the U.S. House of Representatives. She was first elected to Congress in 2008, representing Arizona's 1st congressional district. Kirkpatrick has focused on issues such as healthcare, education, and veterans' services during her time in office. She has been a strong advocate for expanding access to affordable healthcare and has worked on legislation to support military families and veterans. Kirkpatrick has also been involved in efforts to address climate change and promote renewable energy in Arizona.
I believe that it is the wrong time to make changes to the tax code that could make charitable contributions less attractive.
I am opposed to budget proposals that would increase taxes for small business owners and working families.
I strongly support the President's proposed increase of $400 million for Immigrations and Customs Enforcement, or ICE.
I strongly supported provisions in the economic recovery package that will make it easier for solar, wind and other renewable industries to gain access to the capital necessary to deploy these new technologies at speed and scale.
I support the proposal to hire an additional 50,000 officers, and I strongly support sustaining resources for our local communities.
The Mortgage Interest Deduction (MID) is an important incentive that encourages Americans all over the country to buy homes.
I remain concerned about President Obama's proposal to reduce the itemized deduction rate for families with incomes over $250,000.
I applaud the President for scaling back the Yucca Mountain program. For years, Nevadans have fought against this disastrous plan to store nuclear waste in our backyard.
As we face critical challenges ahead, we must work together, Democrats and Republicans.
I believe that this budget should double cancer funding over the coming years and heavily invest in research on Parkinson's, diabetes, and Alzheimer's.





